Stephen E. O'Connor

2.2k total citations
43 papers, 1.9k citations indexed

About

Stephen E. O'Connor is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Stephen E. O'Connor has authored 43 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 13 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in Stephen E. O'Connor's work include Nitric Oxide and Endothelin Effects (11 papers), Receptor Mechanisms and Signaling (7 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Stephen E. O'Connor is often cited by papers focused on Nitric Oxide and Endothelin Effects (11 papers), Receptor Mechanisms and Signaling (7 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Stephen E. O'Connor collaborates with scholars based in France, United Kingdom and United States. Stephen E. O'Connor's co-authors include Paul Leff, Ian Dainty, P. Leff, Beverley Wood, Philip Janiak, Agnès Choppin, Jean‐Marc Herbert, Jean‐Pierre Bidouard, Robert G. Humphries and J B Farmer and has published in prestigious journals such as Circulation, Hypertension and The American Journal of Cardiology.

In The Last Decade

Stephen E. O'Connor

43 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen E. O'Connor France 22 524 460 363 356 226 43 1.9k
Shoshana Zevin Israel 23 594 1.1× 73 0.2× 171 0.5× 852 2.4× 139 0.6× 45 1.9k
Richard Bogle United Kingdom 20 354 0.7× 70 0.2× 330 0.9× 751 2.1× 199 0.9× 48 1.6k
Nigel S. Cook Switzerland 24 1.4k 2.6× 56 0.1× 732 2.0× 544 1.5× 237 1.0× 63 2.6k
Ronald E. Weishaar United States 22 1.2k 2.3× 62 0.1× 968 2.7× 381 1.1× 92 0.4× 48 2.4k
Solomon S. Solomon United States 27 847 1.6× 53 0.1× 130 0.4× 341 1.0× 411 1.8× 75 2.2k
Gerald S. Levey United States 38 1.6k 3.1× 138 0.3× 1.2k 3.3× 681 1.9× 1.0k 4.4× 119 4.4k
Frank Niklasson Sweden 23 302 0.6× 61 0.1× 183 0.5× 363 1.0× 206 0.9× 59 1.4k
Ken Shinmura Japan 34 1.2k 2.2× 68 0.1× 1.0k 2.9× 1.4k 3.9× 859 3.8× 121 4.6k
J A Oates United States 23 383 0.7× 37 0.1× 605 1.7× 331 0.9× 227 1.0× 41 2.2k
Sheila A Doggrell Australia 25 1.2k 2.3× 30 0.1× 822 2.3× 579 1.6× 353 1.6× 346 3.3k

Countries citing papers authored by Stephen E. O'Connor

Since Specialization
Citations

This map shows the geographic impact of Stephen E. O'Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen E. O'Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen E. O'Connor more than expected).

Fields of papers citing papers by Stephen E. O'Connor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen E. O'Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen E. O'Connor. The network helps show where Stephen E. O'Connor may publish in the future.

Co-authorship network of co-authors of Stephen E. O'Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen E. O'Connor. A scholar is included among the top collaborators of Stephen E. O'Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen E. O'Connor. Stephen E. O'Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouloy, Michèle, et al.. (2006). Abstract 1460: Effect of HMR1766, a Soluble Guanylate Cyclase Activator, on Differentiation of Cardiac Fibroblasts and Extracellular Matrix Synthesis Induced by TGFbeta. Circulation. 114. 1 indexed citations
2.
Janiak, Philip, Jean‐Pierre Bidouard, Bruno Poirier, et al.. (2006). Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats. European Journal of Pharmacology. 534(1-3). 271–279. 28 indexed citations
3.
Millet, L., et al.. (2004). SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis. Journal of Thrombosis and Haemostasis. 2(4). 629–636. 2 indexed citations
4.
Masson, Régis, Nigel Roome, Jean-Pascal Hérault, et al.. (2004). Effects of SanOrg123781A, a Synthetic Hexadecasaccharide, in a Mouse Model of Electrically Induced Carotid Artery Injury: Synergism with the Antiplatelet Agent Clopidogrel. Journal of Pharmacology and Experimental Therapeutics. 309(1). 235–240. 15 indexed citations
5.
Altenburger, J.M., Gilbert Lassalle, Zsolt Böcskei, et al.. (2004). SSR182289A, a selective and potent orally active thrombin inhibitor. Bioorganic & Medicinal Chemistry. 12(7). 1713–1730. 117 indexed citations
6.
Bidouard, Jean‐Pierre, et al.. (2003). SSR69071, an elastase inhibitor, reduces myocardial infarct size following ischemia–reperfusion injury. European Journal of Pharmacology. 461(1). 49–52. 17 indexed citations
7.
Millet, L., Catherine Lunven, Catherine Berry, et al.. (2003). Antithrombotic Properties of SSR182289A, a New, Orally Active Thrombin Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 304(2). 567–574. 18 indexed citations
8.
Galzin, Anne‐Marie, et al.. (2000). Effects of SL 65.0472, a novel 5-HT receptor antagonist, on 5-HT receptor mediated vascular contraction. European Journal of Pharmacology. 404(3). 361–368. 11 indexed citations
9.
O'Connor, Stephen E.. (2000). Mode of care delivery in stroke rehabilitation nursing: a development of Kirkevold’s Unified Theoretical Perspective of the role of the nurse. Clinical Effectiveness in Nursing. 4(4). 180–188. 25 indexed citations
10.
O'Connor, Stephen E., et al.. (1999). The pharmacological basis and pathophysiological significance of the heart rate‐lowering property of diltiazem. Fundamental and Clinical Pharmacology. 13(2). 145–153. 40 indexed citations
12.
13.
Lunven, Catherine, et al.. (1996). Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin. British Journal of Pharmacology. 118(3). 727–733. 9 indexed citations
14.
O'Connor, Stephen E.. (1994). The Development of Stroke Units: The British Experience. Rehabilitation Nursing. 19(4). 244–247. 5 indexed citations
15.
Choppin, Agnès & Stephen E. O'Connor. (1994). 5-Hydroxytryptamine1D-like receptors mediate contraction of partially depolarized rabbit renal arteries.. Journal of Pharmacology and Experimental Therapeutics. 270(2). 650–655. 17 indexed citations
16.
O'Connor, Stephen E.. (1993). Nursing and rehabilitation: the interventions of nurses in stroke patient care. Journal of Clinical Nursing. 2(1). 29–34. 52 indexed citations
17.
Lefèvre-Borg, F, Stephen E. O'Connor, H. Schoemaker, et al.. (1993). Alfuzosin, a selective α1‐adrenoceptor antagonist in the lower urinary tract. British Journal of Pharmacology. 109(4). 1282–1289. 69 indexed citations
18.
O'Connor, Stephen E., et al.. (1992). 5-HT4 receptors, present in piglet atria and sensitive to SDZ 205-557, are absent in papillary muscle. European Journal of Pharmacology. 229(1). 105–108. 16 indexed citations
19.
Leff, P., Beverley Wood, & Stephen E. O'Connor. (1990). Suramin is a slowly‐equilibrating but competitive antagonist at P2x‐receptors in the rabbit isolated ear artery. British Journal of Pharmacology. 101(3). 645–649. 125 indexed citations
20.
O'Connor, Stephen E., Beverley Wood, & P. Leff. (1990). Characterization of P2x‐receptors in rabbit isolated ear artery. British Journal of Pharmacology. 101(3). 640–644. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026